Desire for a child and breast cancer

Acta Chirurgica Belgica

Volumn 108, Issue 1, 2008, Pages 83-87

  Liebens, F ^a   Carly, B ^a   Pastijn, A ^a   Fastrez, M ^a   Vandromme, J ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Breast cancer; Cryopreservation; Fertility; Pregnancy

Indexed keywords

EID: 40949131003     PISSN: 00015458     EISSN: 25770160     Source Type: Journal    
DOI: 10.1080/00015458.2008.11680181     Document Type: Review

References (30)

1. GHAFOOR A., JEMAL A., WARD E. et al. Trends in breast cancer by race and ethnicity. CA Cancer J Clin, 2003, 53: 342-355.
2. LEE S. J., SCHOVER L. R., PARTRIDGE A. H. et al. American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients. J Clin Oncol, 2006, 24: 2917-2931.
3. KNOBF M. T. The Influence of Endocrine Effects of Adjuvant Therapy on Quality of Life Outcomes in Younger Breast Cancer Survivors. Oncologist, 2006, 11: 96-110.
4. PARTRIDGE A. H., BURSTEIN H. J., WINER E. P. Side Effects of Chemotherapy and Combined Chemohormonal Therapy in Women With Early-Stage Breast Cancer. J Natl Cancer I Monographs, 2001, 30: 135-142.
5. GOODWIN P. J., ENNIS M., PRITCHARD K. I., TRUDEAU M., HOOD N. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol, 1999, 17: 2365-70.
6. BINES J., OLESKE D. M., COBLEIGH M. A. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Onco, 1996, 114: 1718-1729.
7. GOLDHIRSCH A., GELBER R. D., CASTIGLIORE M. The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. Ann Oncol, 1990, 1: 183-188.
8. GOLDHIRSCH A., GELBER R. D. Life with consequences of breast cancer: pregnancy during and after endocrine therapies. Breast, 2004, 13: 443-445.
9. BARTHELMES L., GATELEY C. A. Tamoxifen and pregnancy. Breast, 2004, 13: 446-451.
10. FALLOWFIELD L. J., HALL A., MAGUIRE P. et al. Psychological effects of being offered choice of surgery for breast cancer. BMJ, 1994, 309: 448.
11. HAYNES R. B., MCKIBBON K., KANNANI R. Systematic review of randomised interventions to assist patients to follow prescriptions for medications. Lancet, 1996, 348: 383-386.
12. GREENFIELD S., KAPLAN S., WARE J. et al. Expanding patient involvement in care: Effects on patient outcomes. Ann Intern Med, 1985, 102: 520-528.
13. WEISS S. M., WENGERT P. A. Jr, MARTINEZ E. M. et al. Patient satisfaction with decision-making for breast cancer therapy. Ann Surg Oncol, 1996, 3: 285-289.
14. PARTRIDGE A. H., GELBER S., PEPPERCORN J. et al Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol, 2004, 22: 4174-4183.
15. THEWES B., MEISER B., TAYLOR A. et al. Fertility- and Menopause-Related Information Needs of Younger Women With a Diagnosis of Early Breast Cancer. J Clin Oncol, 2005, 23: 5155-5165.
16. PARTRIDGE A, SCHAPIRA L. Pregnancy and breast cancer: epidemiology, treatment, and safety issues. Oncology (Williston Park), 2005, 19: 693-7, discussion 697-700.
17. South Western Oncology Group: Phase III randomized study of goserelin for the reduction of premature ovarian failure in women with stage I-IIIA hormone receptor-negative breast cancer undergoing adjuvant chemotherapy SWOG S0230.
18. SONMEZER M., OKTAY K. Fertility preservation in female patients. Hum Reprod Update, 2004, 10: 251-266.
19. PITTAWAY D. E., WENTZ A. C. Evaluation of the exponential rise of serum estradiol concentrations in human menopausal gonadotropin-induced cycles. Fertil Steril, 1983, 40: 763-767.
20. OKTAY K., BUYUK E., DAVIS O. et al. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod, 2003, 18: 90-95.
21. OKTAY K., BUYUK E., LIBERTELLA N. et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol, 2005, 23: 4347-4353.
22. CHEN C. Pregnancy after human oocyte cryopreservation. Lancet, 1986, 19: 884-886.
23. KUWAYAMA M., VAJTA G., KATO O. et al. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online, 2005, 11: 300-308.
24. BORINI A., SCIAJNO R., BIANCHI V. et al. Clinical outcome of oocyte cryopreservation after slow cooling with a protocol utilizing a high sucrose concentration. Hum Reprod, 2006, 21: 512-517.
25. DONNEZ J., DOLMANS M. M., DEMYLLE D. et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet, 2004, 364: 1405-1410.
26. MEIROW D., LEVRON J., ELDAR-GEVA T. et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med, 2005, 353: 318-321.
27. OKTAY K., BUYUK E., VEECK L. et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet, 2004, 363: 837-840.
28. PERROTIN F., MARKET H., BOUQUIN R. et al. Incidence, diagnosis and prognosis of ovarian metastasis in breast cancer. Gynecol Obstet Fertil, 2001, 29: 308-315.
29. JOHNSON J., CANNING J., KANEKO T. et al. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature, 2004, 428: 145-150.
30. JOHNSON J., BAGLEY J., SKAZNIK-WIKIEL M. et al. Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell, 2005, 122: 303-315.